Recombinant monoclonal antibody specially binds to keratin 17 (KRT17). This human anti-KRT17 antibody (A4) can be widely used in treatment of patients with epidermal proliferative dermatoses, especially psoriasis.
Figure 3 Expression of KRT17 in conventional RCC.
Strong KRT17 expression in single tumor cells.
Sarlos, D. P., Yusenko, M. V., Peterfi, L., Szanto, A., & Kovacs, G. (2019). Dual role of KRT17: development of papillary renal cell tumor and progression of conventional renal cell carcinoma. Journal of Cancer, 10(21), 5124.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOR-1981 | Hi-Affi™ Recombinant Rabbit Anti-KRT17 Monoclonal Antibody (DS1981AB) | ICC/IF, IHC-P, IP, WB | IgG |
There are currently no Customer reviews or questions for FAMAB-0260JF. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.